Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Other Accumulated Expenses (2016 - 2025)

Adma Biologics' Other Accumulated Expenses history spans 8 years, with the latest figure at $4.2 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 108.82% year-over-year to $4.2 million; the TTM value through Dec 2025 reached $4.2 million, up 108.82%, while the annual FY2025 figure was $4.2 million, 108.82% up from the prior year.
  • Other Accumulated Expenses reached $4.2 million in Q4 2025 per ADMA's latest filing, up from $2.6 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $17.5 million in Q2 2025 to a low of $981721.0 in Q4 2021.
  • Average Other Accumulated Expenses over 5 years is $3.1 million, with a median of $2.3 million recorded in 2024.
  • Peak YoY movement for Other Accumulated Expenses: crashed 33.89% in 2023, then surged 663.13% in 2025.
  • A 5-year view of Other Accumulated Expenses shows it stood at $981721.0 in 2021, then surged by 82.94% to $1.8 million in 2022, then soared by 31.68% to $2.4 million in 2023, then fell by 15.6% to $2.0 million in 2024, then skyrocketed by 108.82% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Other Accumulated Expenses are $4.2 million (Q4 2025), $2.6 million (Q3 2025), and $17.5 million (Q2 2025).